Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gert Storm

Showing results (31-40 of 392) with videos related to

Pageof 40
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 28, 2011
Drug targeting to tumors: principles, pitfalls and (pre-) clinical progressTwan Lammers, Fabian Kiessling, Wim E Hennink, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 26, 2017
Targeting the Stat6 pathway in tumor-associated macrophages reduces tumor growth and metastatic niche formation in breast cancerKarin Binnemars-Postma, Ruchi Bansal, Gert Storm, et al.
Macromolecular Bioscience|July 15, 2016
Physico-Chemical Strategies to Enhance Stability and Drug Retention of Polymeric Micelles for Tumor-Targeted Drug DeliveryYang Shi, Twan Lammers, Gert Storm, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 26, 2012
Personalized nanomedicineTwan Lammers, Larissa Y Rizzo, Gert Storm, et al.
World Journal of Gastroenterology|March 25, 2020
Role of spleen tyrosine kinase in liver diseasesDhadhang Wahyu Kurniawan, Gert Storm, Jai Prakash, et al.
International Journal of Pharmaceutics|March 18, 2008
In situ gelling hydrogels for pharmaceutical and biomedical applicationsSophie R Van Tomme, Gert Storm, Wim E Hennink
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 6, 2018
Nano-targeted relaxin impairs fibrosis and tumor growth in pancreatic cancer and improves the efficacy of gemcitabine in vivoDeby F Mardhian, Gert Storm, Ruchi Bansal, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 18, 2019
The role of liposomes in clinical nanomedicine development. What now? Now what?Daan J A Crommelin, Peter van Hoogevest, Gert Storm
Frontiers in Oncology|February 3, 2016
MicroRNA Targeting to Modulate Tumor MicroenvironmentPraneeth R Kuninty, Jonas Schnittert, Gert Storm, et al.
Advanced Drug Delivery Reviews|March 5, 2017
The battle of "nano" paclitaxelAlexandros Marios Sofias, Michael Dunne, Gert Storm, et al.
Pageof 40

Showing results (31-40 of 392) with videos related to

Sort By:
Pageof 40
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 28, 2011
Drug targeting to tumors: principles, pitfalls and (pre-) clinical progressTwan Lammers, Fabian Kiessling, Wim E Hennink, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 26, 2017
Targeting the Stat6 pathway in tumor-associated macrophages reduces tumor growth and metastatic niche formation in breast cancerKarin Binnemars-Postma, Ruchi Bansal, Gert Storm, et al.
Macromolecular Bioscience|July 15, 2016
Physico-Chemical Strategies to Enhance Stability and Drug Retention of Polymeric Micelles for Tumor-Targeted Drug DeliveryYang Shi, Twan Lammers, Gert Storm, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 26, 2012
Personalized nanomedicineTwan Lammers, Larissa Y Rizzo, Gert Storm, et al.
World Journal of Gastroenterology|March 25, 2020
Role of spleen tyrosine kinase in liver diseasesDhadhang Wahyu Kurniawan, Gert Storm, Jai Prakash, et al.
International Journal of Pharmaceutics|March 18, 2008
In situ gelling hydrogels for pharmaceutical and biomedical applicationsSophie R Van Tomme, Gert Storm, Wim E Hennink
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 6, 2018
Nano-targeted relaxin impairs fibrosis and tumor growth in pancreatic cancer and improves the efficacy of gemcitabine in vivoDeby F Mardhian, Gert Storm, Ruchi Bansal, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 18, 2019
The role of liposomes in clinical nanomedicine development. What now? Now what?Daan J A Crommelin, Peter van Hoogevest, Gert Storm
Frontiers in Oncology|February 3, 2016
MicroRNA Targeting to Modulate Tumor MicroenvironmentPraneeth R Kuninty, Jonas Schnittert, Gert Storm, et al.
Advanced Drug Delivery Reviews|March 5, 2017
The battle of "nano" paclitaxelAlexandros Marios Sofias, Michael Dunne, Gert Storm, et al.
Pageof 40